image
AN2 Therapeutics, Inc. ANTX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.0
0 %
$ 29.8 M
Market Cap
-0.5
P/E
BALANCE SHEET
139 M ASSETS
35.28%
Growth Rates
1Year 35.28%
3Years 220.00%
5Years 0.00%
7Years 0.00%
10Years 0.00%
14 M LIABILITIES
95.37%
Growth Rates
1Year 95.37%
3Years -16.99%
5Years 0.00%
7Years 0.00%
10Years 0.00%
125 M EQUITY
30.75%
Growth Rates
1Year 30.75%
3Years 101.14%
5Years 0.00%
7Years 0.00%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition AN2 Therapeutics, Inc.
image
Current Assets 111 M
Cash & Short-Term Investments 107 M
Receivables 0
Other Current Assets 3.21 M
Non-Current Assets 28.2 M
Long-Term Investments 27.2 M
PP&E 0
Other Non-Current Assets 1.04 M
Current Liabilities 14 M
Accounts Payable 2.68 M
Short-Term Debt 0
Other Current Liabilities 11.4 M
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019
ASSETS
Cash & Cash Equivalents 15.6 27.2 12.1 4.1 5.6
Short Term Investments 91.6 68.8 46.5 0 0
Receivables 0 0 0 0 0
Inventory 0 0 0 0 0
Other Current Assets 3.2 2.6 1.6 0.2 0.1
Total Current Assets 110.5 98.6 60.1 4.2 5.7
PP&E 0 53 K 0 0 0
Intangible Assets 0 0 0 0 0
Goodwill 0 0 0 0 0
Long Term Investments 27.2 3.2 3.5 0 0
Other Long Term Assets 1.0 0.7 1.7 0 0
Other Assets 0 0 0 0 0
Total Assets 138.7 102.6 65.3 4.2 5.7
LIABILITIES
Accounts Payable 2.7 2.1 1.1 0.1 51 K
Short Term Debt 0 0.1 0 0 0
Other Current Liabilities 11.4 5.0 2.3 1.3 0.1
Total Current Liabilities 14.0 7.2 3.4 1.5 0.2
Long Term Debt 0 0 0 0 0.7
Deferred Tax Income 0 0 0 0 0
Other Liabilities 0 2 K 109.3 23.1 0
Total Liabilities 14.0 7.2 112.7 24.6 0.9
EQUITY
Common Stock 0 0 0 0 0
Retained Earnings (154.5) (89.7) (47.4) (20.3) (5.8)
Other Accumulative Comprehensive Income/Loss 0.3 (0.4) 27 K 0 0
Total Equity 124.7 95.4 (47.4) (20.3) 4.8
Total Liabilities and Equity 138.7 102.6 65.3 4.2 5.7
SHARES OUTSTANDING
Common Shares Outstanding 23.6 19.4 18.7 18.7 18.7